Journal of Korean Medical Science

Korean Acad Medical Sciences (대한의학회)
권호 표지
DOI QR코드

DOI QR Code

The Risk of Abdominal Obesity according to the Degree of Non-Alcoholic Fatty Liver Disease in Korean Men

  • Park, Sung Keun (Total Healthcare Center, Kangbuk Samsung Hospital, Sungkyunkwan University, School of Medicine) ;
  • Ryoo, Jae-Hong (Department of Preventive Medicine, School of Medicine, Kyung Hee University) ;
  • Choi, Joong-Myung (Department of Preventive Medicine, School of Medicine, Kyung Hee University) ;
  • Seo, Min Woo (Department of Preventive Medicine, School of Medicine, Kyung Hee University) ;
  • Park, Chung Min (Department of Preventive Medicine, School of Medicine, Kyung Hee University)
  • Received : 2015.06.10
  • Accepted : 2015.11.13
  • Published : 2016.03.10
⟨ Previous Next ⟩

Abstract

Although non-alcoholic fatty liver disease has been reported as a cardiometabolic risk factor, the effect of non-alcoholic fatty liver is yet to be clarified on abdominal obesity. Therefore, this study was conducted to investigate the longitudinal relationship of non-alcoholic fatty liver on the development of abdominal obesity. The study participants were composed of 11,212 Korean men without abdominal obesity. They were followed up from 2005 to 2010 to be monitored for the development of abdominal obesity according to their degree of non-alcoholic fatty liver disease (normal, mild, and moderate to severe). Cox-proportional hazard model was used to calculate the hazard ratios for abdominal obesity according to the degree of non-alcoholic fatty liver disease. While the average incidence was 15.5%, the incidence of abdominal obesity increased according to the degree of non-alcoholic fatty liver (normal: 11.6%, mild: 25.2%, moderate to severe: 41.0%, P < 0.001). Multivariable-adjusted hazard ratios for abdominal obesity independently increased proportionally to the degree of NAFLD (mild [1.07; 0.94-1.23], moderate to severe [1.58; 1.11-2.26], P for trend < 0.001). The risk of abdominal obesity increased proportionally to the degree of non-alcoholic fatty liver disease. This finding guarantees further studies to reveal the incidental relationship of abdominal obesity with non-alcoholic fatty liver disease.

Keywords

References

  1. World Health Organization. Obesity and overweight. Available at http://www.who.int/mediacentre/factsheets/fs311/en/index.html [accessed on 1 June 2014].
  2. Kelly T, Yang W, Chen CS, Reynolds K, He J. Global burden of obesity in 2005 and projections to 2030. Int J Obes 2008; 32: 1431-7. https://doi.org/10.1038/ijo.2008.102
  3. Coutinho T, Goel K, Corrêa de Sá D, Kragelund C, Kanaya AM, Zeller M, Park JS, Kober L, Torp-Pedersen C, Cottin Y, et al. Central obesity and survival in subjects with coronary artery disease: a systematic review of the literature and collaborative analysis with individual subject data. J Am Coll Cardiol 2011; 57: 1877-86. https://doi.org/10.1016/j.jacc.2010.11.058
  4. Anjana M, Sandeep S, Deepa R, Vimaleswaran KS, Farooq S, Mohan V. Visceral and central abdominal fat and anthropometry in relation to diabetes in Asian Indians. Diabetes Care 2004; 27: 2948-53. https://doi.org/10.2337/diacare.27.12.2948
  5. Després JP, Lemieux I. Abdominal obesity and metabolic syndrome. Nature 2006; 444: 881-7. https://doi.org/10.1038/nature05488
  6. Hojgaard B, Olsen KR, Sogaard J, Sorensen TI, Gyrd-Hansen D. Economic costs of abdominal obesity. Obes Facts 2008; 1: 146-54. https://doi.org/10.1159/000137822
  7. Angulo P. Nonalcoholic fatty liver disease. N Engl J Med 2002; 346:1221-31. https://doi.org/10.1056/NEJMra011775
  8. Neuschwander-Tetri BA, Caldwell SH. Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference. Hepatology 2003; 37: 1202-19. https://doi.org/10.1053/jhep.2003.50193
  9. Ryoo JH, Choi JM, Moon SY, Suh YJ, Shin JY, Shin HC, Park SK. The clinical availability of non alcoholic fatty liver disease as an early predictor of the metabolic syndrome in Korean men: 5-year's prospective cohort study. Atherosclerosis 2013; 227: 398-403. https://doi.org/10.1016/j.atherosclerosis.2013.01.002
  10. Nishiura T, Watanabe H, Ito M, Matsuoka Y, Yano K, Daikoku M, Yatsuhashi H, Dohmen K, Ishibashi H. Ultrasound evaluation of the fibrosis stage in chronic liver disease by the simultaneous use of low and high frequency probes. Br J Radiol 2005; 78: 189-97. https://doi.org/10.1259/bjr/75208448
  11. Hung CH, Lu SN, Wang JH, Lee CM, Chen TM, Tung HD, Chen CH, Huang WS, Changchien CS. Correlation between ultrasonographic and pathologic diagnoses of hepatitis B and C virus-related cirrhosis. J Gastroenterol 2003; 38: 153-7. https://doi.org/10.1007/s005350300025
  12. Saadeh S, Younossi ZM, Remer EM, Gramlich T, Ong JP, Hurley M, Mullen KD, Cooper JN, Sheridan MJ. The utility of radiological imaging in nonalcoholic fatty liver disease. Gastroenterology 2002; 123: 745-50. https://doi.org/10.1053/gast.2002.35354
  13. Hernaez R, Lazo M, Bonekamp S, Kamel I, Brancati FL, Guallar E, Clark JM, Cooper JN, Sheridan MJ. Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: a meta-analysis. Hepatology 2011; 54: 1082-90.
  14. Mottin CC, Moretto M, Padoin AV, Swarowsky AM, Toneto MG, Glock L, Repetto G. The role of ultrasound in the diagnosis of hepatic steatosis in morbidly obese patients. Obes Surg 2004; 14: 635-7. https://doi.org/10.1381/096089204323093408
  15. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WP, Loria CM, Smith SC Jr, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009; 120: 1640-5. https://doi.org/10.1161/CIRCULATIONAHA.109.192644
  16. Ruhl CE, Everhart JE. Determinants of the association of overweight with elevated serum alanine aminotransferase activity in the United States. Gastroenterology 2003; 124: 71-9. https://doi.org/10.1053/gast.2003.50004
  17. Pagano G, Pacini G, Musso G, Gambino R, Mecca F, Depetris N, Cassader M, David E, Cavallo-Perin P, Rizzetto M. Nonalcoholic steatohepatitis, insulin resistance, and metabolic syndrome: further evidence for an etiologic association. Hepatology 2002; 35: 367-72. https://doi.org/10.1053/jhep.2002.30690
  18. Sanyal AJ, Campbell-Sargent C, Mirshahi F, Rizzo WB, Contos MJ, Sterling RK, Luketic VA, Shiffman ML, Clore JN. Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities. Gastroenterology 2001; 120: 1183-92. https://doi.org/10.1053/gast.2001.23256
  19. Mehran AE, Templeman NM, Brigidi GS, Lim GE, Chu KY, Hu X, Botezelli JD, Asadi A, Hoffman BG, Kieffer TJ, et al. Hyperinsulinemia drives diet-induced obesity independently of brain insulin production. Cell Metab 2012; 16: 723-37. https://doi.org/10.1016/j.cmet.2012.10.019
  20. McNay EC, Teske JA, Kotz CM, Dunn-Meynell A, Levin BE, McCrimmon RJ, Sherwin RS. Long-term, intermittent, insulin-induced hypoglycemia produces marked obesity without hyperphagia or insulin resistance: a model for weight gain with intensive insulin therapy. Am J Physiol Endocrinol Metab 2013; 304: E131-8. https://doi.org/10.1152/ajpendo.00262.2012
  21. Russell-Jones D, Khan R. Insulin-associated weight gain in diabetes--causes, effects and coping strategies. Diabetes Obes Metab 2007; 9: 799-812. https://doi.org/10.1111/j.1463-1326.2006.00686.x
  22. Bedogni G, Miglioli L, Masutti F, Tiribelli C, Marchesini G, Bellentani S. Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study. Hepatology 2005; 42: 44-52.
  23. Joy D, Thava VR, Scott BB. Diagnosis of fatty liver disease: is biopsy necessary? Eur J Gastroenterol Hepatol 2003; 15: 539-43.
  24. Mathiesen UL, Franzen LE, Aselius H, Resjoo M, Jacobsson L, Foberg U, Fryden A, Bodemar G. Increased liver echogenicity at ultrasound examination reflects degree of steatosis but not of fibrosis in asymptomatic patients with mild/moderate abnormalities of liver transaminases. Dig Liver Dis 2002; 34: 516-22. https://doi.org/10.1016/S1590-8658(02)80111-6
  25. Scatarige JC, Scott WW, Donovan PJ, Siegelman SS, Sanders RC. Fatty infiltration of the liver: ultrasonographic and computed tomographic correlation. J Ultrasound Med 1984; 3: 9-14. https://doi.org/10.7863/jum.1984.3.1.9
  26. Graif M, Yanuka M, Baraz M, Blank A, Moshkovitz M, Kessler A, Gilat T, Weiss J, Walach E, Amazeen P, et al. Quantitative estimation of attenuation in ultrasound video images: correlation with histology in diffuse liver disease. Invest Radiol 2000; 35: 319-24. https://doi.org/10.1097/00004424-200005000-00006

Cited by

  1. The Risk for Insulin Resistance according to the Degree of Non-Alcoholic Fatty Liver Disease in Korean Men vol.31, pp.11, 2016, https://doi.org/10.3346/jkms.2016.31.11.1761
  2. Hemorheological Alteration in Patients Clinically Diagnosed with Chronic Liver Diseases vol.31, pp.12, 2016, https://doi.org/10.3346/jkms.2016.31.12.1943
  3. Associations among the Degree of Nonalcoholic Fatty Liver Disease, Metabolic Syndrome, Degree of Obesity in Children, and Parental Obesity vol.19, pp.3, 2016, https://doi.org/10.5223/pghn.2016.19.3.199
  4. Effect of non-alcoholic fatty liver disease on left ventricular diastolic function and geometry in the Korean general population : NAFLD, left ventricular diastolic dysfunction vol.47, pp.6, 2017, https://doi.org/10.1111/hepr.12770
  5. Lobeglitazone, a Novel Thiazolidinedione, Improves Non-Alcoholic Fatty Liver Disease in Type 2 Diabetes: Its Efficacy and Predictive Factors Related to Responsiveness vol.32, pp.1, 2016, https://doi.org/10.3346/jkms.2017.32.1.60
  6. FEATURES OF SOME ANTHROPOMETRIC INDICES AND INDICES OF INSULIN RESISTANCE IN PATIENTS WITH NON-ALCOHOLIC STEATOHEPATITIS ON THE BACKGROUND OF OBESITY AND OSTEOARTHRITIS vol.73, pp.4, 2016, https://doi.org/10.36740/wlek202004123
  7. Association of obesity, visceral adiposity, and sarcopenia with an increased risk of metabolic syndrome: A retrospective study vol.16, pp.8, 2021, https://doi.org/10.1371/journal.pone.0256083